Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis
- PMID: 19193658
- DOI: 10.1093/jac/dkp007
Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis
Abstract
Objectives: To investigate variability in colony morphology and antibiotic susceptibility in populations of Pseudomonas aeruginosa from sputa of patients with bronchiectasis without cystic fibrosis (CF) compared with P. aeruginosa isolated from patients with CF, and from other infections as controls.
Methods: P. aeruginosa was cultured from 31 patients with non-CF bronchiectasis, 24 with CF, 7 ventilated patients and 9 skin swabs. Four colonies of each morphotype of P. aeruginosa were tested for susceptibility to 12 antibiotics by disc diffusion. The variability in susceptibility between the isolates in each patient's population of P. aeruginosa was investigated.
Results: The classic morphotype of P. aeruginosa was cultured from control samples with an average variation in zone size of 2 mm (range 0-4 mm) for the four colonies tested. Non-CF bronchiectasis sputa contained 1-3 colonial morphotypes of P. aeruginosa; the average difference between the largest and smallest zone sizes found in all examples of the morphotypes present in each sample varied from 3 mm (1-9 mm) for colistin to 8 mm (0-24 mm) for piperacillin/tazobactam. CF sputa contained 2-6 morphotypes of P. aeruginosa with a wider variation of susceptibility. There was variation between bacteria of the same morphotype from non-CF bronchiectasis and CF sputa.
Conclusions: Phenotypic variation in colonial form and antibiotic susceptibility is not unique to chronic infection in CF but is also found in non-CF bronchiectasis. This questions the use of current susceptibility testing methods for the complex populations of bacteria found in chronic lung infection.
Similar articles
-
Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.J Antimicrob Chemother. 2005 Jun;55(6):921-7. doi: 10.1093/jac/dki146. Epub 2005 May 9. J Antimicrob Chemother. 2005. PMID: 15883175
-
Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.J Antimicrob Chemother. 2008 May;61(5):1057-61. doi: 10.1093/jac/dkn081. Epub 2008 Mar 3. J Antimicrob Chemother. 2008. PMID: 18316821
-
[Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].Mikrobiyol Bul. 2009 Oct;43(4):563-73. Mikrobiyol Bul. 2009. PMID: 20084909 Turkish.
-
The approach to Pseudomonas aeruginosa in cystic fibrosis.Semin Respir Crit Care Med. 2009 Oct;30(5):587-95. doi: 10.1055/s-0029-1238917. Epub 2009 Sep 16. Semin Respir Crit Care Med. 2009. PMID: 19760546 Review.
-
Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.Trends Microbiol. 2009 Mar;17(3):130-8. doi: 10.1016/j.tim.2008.12.003. Epub 2009 Feb 21. Trends Microbiol. 2009. PMID: 19231190 Review.
Cited by
-
Efficient photodynamic therapy against gram-positive and gram-negative bacteria using THPTS, a cationic photosensitizer excited by infrared wavelength.PLoS One. 2010 Jul 20;5(7):e11674. doi: 10.1371/journal.pone.0011674. PLoS One. 2010. PMID: 20652031 Free PMC article.
-
Virulence adaptations of Pseudomonas aeruginosa isolated from patients with non-cystic fibrosis bronchiectasis.Microbiology (Reading). 2016 Dec;162(12):2126-2135. doi: 10.1099/mic.0.000393. Microbiology (Reading). 2016. PMID: 27902425 Free PMC article.
-
Antibiotic efficacy in the complex infection environment.Curr Opin Microbiol. 2018 Apr;42:19-24. doi: 10.1016/j.mib.2017.09.007. Epub 2017 Oct 6. Curr Opin Microbiol. 2018. PMID: 28988156 Free PMC article. Review.
-
Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Clin Microbiol Rev. 2014 Oct;27(4):753-82. doi: 10.1128/CMR.00022-14. Clin Microbiol Rev. 2014. PMID: 25278574 Free PMC article. Review.
-
Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.Clin Microbiol Rev. 2018 Aug 29;31(4):e00019-18. doi: 10.1128/CMR.00019-18. Print 2018 Oct. Clin Microbiol Rev. 2018. PMID: 30158299 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical